Anush Shares and Securities

CLOSE X
Equity 
YOU ARE ON : Home | Equity | Comapny Profile | Summary
Summary
Ajanta Pharma Ltd.
BSE CODE: 532331   |   ISIN CODE : INE031B01049
BSE
2081.75
2.05 ( 0.1% )
 
Prev Close ( Rs.)
2079.70
Open ( Rs.)
2063.45
 
High ( Rs.)
2103.50
Low ( Rs.)
2063.45
 
Volume
1788
Week Avg.Volume
3391
 
52 WK High-Low Range
BSE NSE
2085.40
6.55 ( 0.32% )
 
Prev Close ( Rs.)
2078.85
Open ( Rs.)
2078.85
 
High ( Rs.)
2107.95
Low ( Rs.)
2069.15
 
Volume
34465
Week Avg.Volume
65215
 
52 WK High-Low Range
1246.75
2353.95
1D   | 1M   | 3M   | 1Y  | 3Y  | 5Y
You need to upgrade your Flash Player
Competitors
Company NameLast Price (Rs.)Chg (Rs./%)Sales TurnOverVolume
Bharat Parenterals1455.20132.25(10.00)329.9410118.00
Solara Active Pharma551.4577.35(16.32)417.24338258.00
Abbott India26131.8576.20(0.29)1480.48275.00
Windlas Biotech555.0536.15(6.97)191.086334.00
Concord Biotech1595.2516.60(1.05)123.508060.00
More>
KEY PERSONNEL & ADDRESS
Chairman
Mannalal B Agrawal
Managing Director
Yogesh M Agrawal
Company Secretary
Gaurang Shah
Registered Office :
Ajanta House,Charkop ,Kandivali (W), Mumbai,
Maharashtra-400067 .
Phone :
022-66061000  
E-mail :
legal.info@ajantapharma.com
URL
www.ajantapharma.com
 
News On AJANTPHARM
15/04/2024
Ajanta Pharma informs about co...
30/03/2024
Ajanta Pharma informs about di...
31/01/2024
Cancellation Of Employee Stoc...
25/01/2024
Ajanta Pharma informs about up...
More >
Financials
QUARTERLY (Dec 23)
Net Profit( Rs . In Cr) 2201.5
Gross Profit( Rs . In Cr) 3051.4
Operating Profit( Rs . In Cr) 3409.1
Net Sales( Rs .In Cr) 10852.9
More>
MF Holding Details
Scheme NameMkt value (In Cr.)
Nippon India Small C...405.15
UTI Flexi Cap Fund-R...361.98
Kotak Small Cap Fund...221.36
Nippon India Pharma ...215.99
HDFC Large and Mid C...175.33
Invesco India Contra...172.95
UTI Mid Cap Fund-Reg...150.96
More>
Attention Investors: "Prevent Unauthorized Transactions in your account --> Update your Mobile Numbers/email IDs with your stock brokers. Receive information of your transactions directly from exchange on your mobile/email at the end of the day..... issued in the interest of investors. "
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account
Prevent Unauthorized Transactions in your demat account:Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Exchange / CDSL on the same day.........issued in the interest of investors.
SEBI REGN NO: INZ000271235 | DP~IN-DP 672-2022 | Member ID : NSE :14453 | BSE: 6281 | MCX-SX: 11280 |SCM F&O: M50171 | AMFI: 2110
Segregation and Monitoring of Collateral at Client Level with reference to NCL circulars NCL/CMPL/49348 dated August 20, 2021, NCL/CMPL/49640 dated September 17, 2021 and NCL/CMPL/49764 dated September 29, 2021 on the captioned subject
Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.
Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.
Pay 20% upfront margin of the transaction value to trade in cash market segment.
Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 and BSE vide notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 dated August 31, 2020 and other guidelines issued from time to time in this regard 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month........... Issued in the interest of Investors. "

BSE
×